SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-18-043612
Filing Date
2018-11-23
Accepted
2018-11-23 16:00:49
Documents
4
Group Members
CIPLA (EU) LTDCIPLA LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D formsc13d.htm SC 13D 200932
2 EXHIBIT A ex99_a.htm EX-99.A 9028
3 EXHIBIT D ex99_d.htm EX-99.D 126093
4 EXHIBIT E ex99_e.htm EX-99.E 168758
  Complete submission text file 0001140361-18-043612.txt   506369
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Subject) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90144 | Film No.: 181199670
SIC: 2834 Pharmaceutical Preparations

Mailing Address SITE B 7 OSER AVE. HAUPPAUGE NY 11788
Business Address SITE B 7 OSER AVE. HAUPPAUGE NY 11788 631-231-3233
InvaGen Pharmaceuticals, Inc. (Filed by) CIK: 0001759453 (see all company filings)

IRS No.: 201420845 | State of Incorp.: NY | Fiscal Year End: 0331
Type: SC 13D